NeXusResearch Partners

Building physician referral networks for clinical research

NeXus Research Partners helps research sites build relationships with local physicians whose patients may be eligible for a study. We introduce the investigator and study coordinator through a short video interview, follow up personally, and make it easy for physicians to ask questions or refer a patient directly to the study team.

Our approach starts with the relationship between physicians, not a patient database or automated matching.

Talk with us
Research site Community physicians

Approach

A referral starts with knowing who is on the other end

Before bringing up a study with a patient, a physician may want to know who will see the patient, what participation involves, and how the study team and the referring practice will work together.

The interview lets physicians hear from the people who would receive the referral. The investigator explains the research question and who might be considered. The coordinator explains what happens after a physician reaches out and how the study team can coordinate with the referring practice around the patient's ongoing care.

How it works

How a physician referral network takes shape

The approval path

SiteThe research site submits our scope, budget and timeline to the sponsor.
SponsorThe sponsor approves the script first, then the interview video, outreach copy and study summary.
IRBThe IRB reviews the materials before any outreach begins.

Reporting. We report which practices were reached, how physicians engaged, and which relationships are worth deepening next. When the site provides aggregate data, we include referrals, screenings, and enrollments.

Numbers tell you what happened. Relationships tell you what happens next.

For the research site

Your office team stays focused on study care

NeXus takes the physician outreach and the inbox work off the office team.

Your study team keeps

  • Clinical questions, eligibility, and consent
  • Prescreening and study care
  • The conversation between the referring physician and the lead investigator
  • Submitting our scope, budget, and timeline to the sponsor

NeXus takes on

  • Physician outreach and personal follow up
  • The physician inbox: nonclinical replies, and arranging meetings with the investigator
  • The interview video, outreach copy, and study summary
  • Reporting on who was reached and how they engaged

Fees

NeXus charges a fixed fee for agreed services at fair market value. We do not tie our fees to referrals or enrollment, and we do not pay physicians for patient referrals.

Guardrails

We describe the study and its eligibility criteria. We make no claims about the safety or efficacy of an investigational product. The research site handles clinical questions, eligibility, and consent. NeXus does not request or receive patient records or identifiers.

Sample

See what a physician hears

Illustrative sample. Study details are generalized, and the sample is not approved copy.

Sample interview script
NeXus

Sample physician interview script

Illustrative sample

The questions, the answers, and what must be confirmed before anyone records. Six pages.

The live site will offer this as a PDF download.

About

Why I started NeXus

When I thought about what I wanted to do next, I kept coming back to clinical research. I wanted to get closer to the work that makes life-changing treatments possible and help more patients have the chance to take part in it.

At Merck, as a cardiovascular Medical Science Liaison, I helped build referral relationships between specialists and community physicians. At Johnson & Johnson, I led global marketing for SIMPONI in immunology and later co-led the respiratory therapeutic area. Across that work, I worked directly with global, national and regional key opinion leaders (KOLs) on programs spanning Phase I through Phase III. I started NeXus to bring those two parts of my career together: helping specialists who lead clinical trials build referral networks with the community physicians whose patients may benefit from knowing a study is open.

Shubhalok Ghosh

Shubhalok Ghosh

Founder and Managing Partner

Shubhalok led vaccine businesses in Japan and Australia.

At Johnson & Johnson, he served as Co-Therapeutic Area Head for Respiratory, leading therapeutic area strategy across eight Phase I and II candidates. He later served as Chief Marketing Officer at Therakos and helped build TCS's digital experience and transformation practice to more than $300 million, serving clients including life sciences and healthcare companies.

At NeXus, Shubhalok leads the work with research sites and sponsors and conducts the interviews that introduce investigators and study coordinators to referring physicians. LinkedIn profile

Advisory board

Evan Gliptis

Evan Gliptis, PharmD

Medical Affairs and Physician Engagement

Evan held Director and Medical Science Liaison roles at Johnson & Johnson, working with specialists across rheumatology, gastroenterology, and dermatology. Earlier, he managed Phase IV oncology trials at GSK and worked as a Clinical Research Associate at IQVIA. He currently practices as a community pharmacist, where he works directly with patients and conducts vaccination clinics. He brings a medical affairs and community practice perspective to how NeXus approaches physician outreach.

Dr. Jonathan Hartman

Dr. Jonathan Hartman, MD

Referring Physician Perspective

Jonathan is Director of Neurointerventional Radiology and Co-Director of the Comprehensive Stroke Center at Kaiser Permanente Sacramento. He treats patients with conditions including acute ischemic stroke, intracranial aneurysms, and arteriovenous malformations. He has co-authored published research on acute ischemic stroke and endovascular stroke treatment. He helps NeXus think through what referring physicians need to know before sending a patient to a study site.

Giri Krishnamoorthy

Giri Krishnamoorthy, MBA

Clinical Development and Commercial Strategy

Giri is Executive Vice President and Global Commercial Lead at ILiAD Biotechnologies. He began his career in clinical operations in global clinical operations at GSK and Centocor. At IQVIA, he worked with emerging biotech companies supporting their early-to-late stage clinical development and connecting with commercial strategy. He previously led global commercial strategy for GSK's pneumococcal vaccine franchise and UK Vaccines Business Unit. He brings a biotech sponsor's perspective to how NeXus plans outreach around a study's development goals.

John Carrier

John Carrier, PhD, MBA

Process Design

John is a Senior Lecturer in System Dynamics at MIT Sloan School of Management and an expert in improving complex operations. He teaches and speaks to leaders across industries about "hidden factories": the workarounds, rework, and delays that make processes harder to run. At NeXus, he applies that lens to the referral process, helping keep it practical for referring practices and study teams.

Advisory board members serve in a personal capacity. Their views are their own and do not represent their employers or institutions. Affiliations are listed for identification only.

Experience

Experience across therapeutic areas

The team has worked on clinical trials in immunology and rheumatology, gastroenterology, dermatology, respiratory disease, cardiovascular and metabolic disease, vaccines and infectious diseases, oncology, and rare diseases.

  • Immunology and rheumatologyrheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis, psoriasis
  • GastroenterologyCrohn's disease and ulcerative colitis
  • Respiratoryasthma, allergic rhinitis, COPD
  • Cardiovascular and metabolichypercholesterolemia, hypertension, diabetes
  • Vaccines and infectious diseases
  • Oncologycutaneous T cell lymphoma
  • Rare diseasesgraft versus host disease, pulmonary sarcoidosis, systemic lupus erythematosus, systemic sclerosis (scleroderma), Sjögren's disease
  • Neurology and neurovascular careDr. Hartman's clinical work includes acute ischemic stroke, intracranial aneurysms, arteriovenous malformations, and carotid and intracranial stenosis.

Questions

Questions physicians and research teams ask

Do my patients stay with me?

Yes. The referring physician continues to manage routine care, and the study team handles study care. At the start, the study team and your office agree on how they will communicate. Any patient records are shared through the research site's secure process. NeXus does not receive patient information.

Who answers clinical questions?

The research site's investigator and study team. NeXus handles outreach and nonclinical replies, and our goal in every conversation is a meeting between you and the lead investigator.

What should I send in my reply?

Please do not include patient names or medical records. Reply to ask for a conversation. The research site handles prescreening, eligibility, and consent.

Is anyone paid for referrals?

No. We do not pay physicians for patient referrals. NeXus charges a fixed fee for agreed services at fair market value, and our fees are not tied to referrals or enrollment.

Who reviews what NeXus sends?

The sponsor approves the script first, then the interview video, outreach copy, and study summary. The IRB reviews the materials before any outreach begins.

What will the sponsor and the site see?

We report which practices were reached, how physicians engaged, and which relationships are worth deepening next. When the site provides aggregate data, we include referrals, screenings, and enrollments.

How is this different from advertising or a patient database?

We do not use a patient database or automated matching. Outreach goes to physicians, and the conversation is between physicians.

Contact

Start a conversation

If you're planning physician outreach for a clinical study, tell us about the protocol, the site, and the physicians you want to reach.

215-901-2222

info@nexusresearchpartnersgroup.com

To request a proposal, call or email us with the study, the research site, and the timeline. A written proposal with scope, approvals, and a fixed fee will follow.